Company Filing History:
9 out of 55 
4 out of 1,974 
Years Active: 2006-2014
Title: Jerk Vallgårda: Innovator in Pharmaceutical Compounds
Introduction
Jerk Vallgårda is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors for specific enzymes. With a total of five patents to his name, Vallgårda's work is recognized for its potential impact on medical treatments.
Latest Patents
Vallgårda's latest patents focus on inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1. The first patent relates to compounds with the formula (II) and includes pharmaceutical compositions that utilize these compounds. The invention also details processes for their preparation and their application in medicine, specifically targeting the human 11-beta-hydroxysteroid dehydrogenase type 1 enzyme. The second patent similarly addresses compounds with the formula (I) and outlines their use in creating medicaments that act on the same enzyme.
Career Highlights
Jerk Vallgårda is currently associated with Biovitrum AB, a company known for its focus on biotechnology and pharmaceuticals. His work at Biovitrum has allowed him to explore innovative solutions in the medical field, contributing to advancements in drug development.
Collaborations
Throughout his career, Vallgårda has collaborated with notable colleagues, including Marianne Nilsson and Guido Kurz. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.
Conclusion
Jerk Vallgårda's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work continues to pave the way for new treatments that could significantly benefit patients worldwide.